Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer

Camblin, A. J., Pace, E. A., Adams, S., Curley, M. D., Rimkunas, V., Nie, L., Tan, G., Bloom, T., Iadevaia, S., Baum, J., Minx, C., Czibere, A., Louis, C. U., Drummond, D. C., Nielsen, U. B., Schoeberl, B., Pipas, J. M., Straubinger, R. M., Askoxylakis, V., Lugovskoy, A. A.
The American Association for Cancer Research (AACR)
Published 2018